Abstract

Elacestrant - cancer du sein localement avancé ou métastatique ER+/HER2-, présentant une mutation activatrice d'ESR1

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call